Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects

被引:24
作者
Gaud, U
Langer, B
Petropoulou, T
Thomas, HC
Karayiannis, P
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med A, London W2 1NY, England
[2] Genet Inst Inc, Dept Clin Res & Dev, Munich, Germany
[3] Univ Munich, Childrens Hosp, Immunodeficiency Clin, D-80539 Munich, Germany
关键词
hepatitis C virus; hypervariable region 1; agammaglobulinaemia; XLA; common variable immunodeficiency disease;
D O I
10.1002/jmv.10296
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The N-terminal end of the hepatitis C virus (HCV) envelope glycoprotein E2 contains a stretch of 27 amino acids that exhibit increased variability. This hypervariable region 1 (HVR-1), as it is normally referred to, is thought to contain epitopes that come under humoral immune attack. In the present study, 10 patients (5 children and 5 adults) with humoral immune defects and chronic HCV infection were investigated, to see how HVR-1 sequences behave overtime in these patients who are unable to produce antibodies. Amplicons of this region showed little or no variation at all over time, indicating that quasi-species variation in this region is driven by the host's humoral immune response.
引用
收藏
页码:350 / 356
页数:7
相关论文
共 38 条
[1]   DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS [J].
ALTER, HJ ;
PURCELL, RH ;
SHIH, JW ;
MELPOLDER, JC ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1494-1500
[2]   TO C OR NOT TO C - THESE ARE THE QUESTIONS [J].
ALTER, HJ .
BLOOD, 1995, 85 (07) :1681-1695
[3]   Primary immunodeficiency disorders: Antibody deficiency [J].
Ballow, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (04) :581-591
[4]   Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients [J].
Booth, JCL ;
Kumar, U ;
Webster, D ;
Monjardino, J ;
Thomas, HC .
HEPATOLOGY, 1998, 27 (01) :223-227
[5]  
Buckley Rebecca H., 1993, P1353
[6]   Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence [J].
Cerny, A ;
Chisari, FV .
HEPATOLOGY, 1999, 30 (03) :595-601
[7]  
CONLEY ME, 1992, ENCY IMMUNOLOGY, V1, P260
[8]  
COOPER MD, 1994, HARRISONS PRINCIPLES, V2, P1559
[9]   Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia [J].
Cramp, ME ;
Carucci, P ;
Rossol, S ;
Chokshi, S ;
Maertens, G ;
Williams, R ;
Naoumov, NV .
GUT, 1999, 44 (03) :424-429
[10]   High prevalence of hypervariable region 1-specific and -cross-reactive CD4+ T cells in HCV-infected individuals responsive to IFN-α treatment [J].
Del Porto, P ;
Puntoriero, G ;
Scottà, C ;
Nicosia, A ;
Piccolella, E .
VIROLOGY, 2000, 269 (02) :313-324